La terapia anticoagulante nel paziente con miocardiopatia dilatativa

Translated title of the contribution: Anticoagulant treatment in patients with dilated cardiomyopathy

G. F. Gensini, C. Rostagno

Research output: Contribution to journalArticlepeer-review

Abstract

Heart failure due to dilated cardiomyopathy is associated with a significant increase in risk of thromboembolism. The incidence can be estimated, on the average, at 2.0-2.5 events per 100 patients per year. At this time, in the absence of randomized trials, limited evidence exists to support the use of anticoagulant treatment for patients with heart failure due to dilated cardiomyopathy in sinus rhythm, even if these subjects appear to be at higher risk than those with ischemic cardiomyopathy and comparable degree of left ventricular dysfunction. Women with left ventricular ejection fraction

Translated title of the contributionAnticoagulant treatment in patients with dilated cardiomyopathy
Original languageItalian
Pages (from-to)227-232
Number of pages6
JournalAnnali Italiani di Medicina Interna
Volume13
Issue number4
Publication statusPublished - 1998

ASJC Scopus subject areas

  • Internal Medicine

Fingerprint Dive into the research topics of 'Anticoagulant treatment in patients with dilated cardiomyopathy'. Together they form a unique fingerprint.

Cite this